Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label cognitive reserve. Show all posts
Showing posts with label cognitive reserve. Show all posts

Saturday, August 1, 2026

The aging brain that doesn’t fail: how neural resilience masks neurodegeneration

Have your competent? doctor provide you EXACT PROTOCOLS for cognitive reserve and resilience. A competent? doctor would have distributed the recovery protocol that Pedro Bach-y-Rita  used to recover fully back in 1958 with only a partial brain! But you don't have a competent doctor, do you? Hasn't done anything so you can be like Bernadette the nun? Lost the link but your doctor should know about her.

NO? So, willing to DO NOTHING, LIKE USUAL!

cognitive reserve (51 posts to November 2014)
cognitive resilience (18 posts to September 2014)

cognitive rehabilitation (34 posts to December 2015)

 The aging brain that doesn’t fail: how neuralresilience masks neurodegeneration

Andrew Eisen , Heather D. Durham & Erik Pioro To cite this article: Andrew Eisen , Heather D. Durham & Erik Pioro (27 Jul 2026): The aging brain that doesn’t fail: how neural resilience masks neurodegeneration, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, DOI: 10.1080/21678421.2026.2705693 To link to this article: https://doi.org/10.1080/21678421.2026.2705693
ANDREW EISEN 1 2 1 , HEATHER D. DURHAM 2 & ERIK PIORO 1 Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada, and Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada 

Abstract 


 Neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease are usually framed as consequences of aging-related pathogenic processes, including impaired proteostasis with protein aggregation, mitochondrial dysfunction, oxidative stress, and neuroinflammation. Yet, most individuals, even into advanced age, do not develop clinically significant neurodegenerative disease. This discrepancy suggests that the nervous system possesses robust and redundant protective mechanisms that maintain neural integrity despite cumulative molecular and cellular stress. In this perspective, we propose that neurodegenerative diseases arise not simply from the presence of pathogenic processes, but when integrated resilience systems fail to maintain homeostasis or when reserve mechanisms no longer compensate for accumulated pathology. We have synthesized a threshold-based model of disease emergence based on evidence across proteostasis, mitochondrial function, neuroimmune regulation, glial biology, network-level compensation, and barrier integrity, while integrating genetic, environmental, developmental, and stochastic modifiers. We distinguish biological resilience, which actively limits or repairs pathology, from reserve, which permits function despite pathology. We further propose that clinical disease emerges only when age-related cumulative stress exceeds the combined capacity of resilience and reserve. Reframing neurodegeneration as a failure of preservation systems offers new directions for pre vention and therapeutic development. 

Keywords: Aging, neurodegeneration, senescence, resilience 

Sunday, June 28, 2026

Cognitive-motor network integration as a behavioral marker of cognitive reserve in post-stroke rehabilitation

 This did nothing to answer the real need! HOW EXACTLY DO YOU REBUILD COGNITIVE RESERVE post stroke so you can weather getting dementia/Alzheimers (per Bernadette the nun) and not have problems?

Cognitive-motor network integration as a behavioral marker of cognitive reserve in post-stroke rehabilitation


  • 1. Faculty of Psychology, University of Innsbruck, Innsbruck, Austria

  • 2. Kliniken Valens, Rheinburg Klinik, Walzenhausen, Switzerland

Abstract

Background:

Functional recovery after stroke varies substantially between individuals, even after standardized inpatient rehabilitation. Cognitive reserve is increasingly considered a key determinant of recovery potential, yet it is typically approximated using indirect proxy measures that may not capture the underlying functional mechanisms of recovery. Network-based approaches may provide a more mechanistic operationalization of cognitive reserve.

Objective: 

This study investigated whether (a) traditional cognitive reserve proxies predict rehabilitation response, (b) responders differ from non-responders in respect to baseline cognitive performance structure, and (c) rehabilitation response is associated with greater cross-domain cognitive-motor network integration at admission.

Methods: 

In this retrospective cohort study, 100 patients (≥ 65 years) with ischemic stroke were included. Functional outcomes were assessed using a battery of motor tests at admission and discharge. A responder was defined as someone who improved in at least two functional domains. Cognitive performance was assessed using the CERAD battery. Cognitive reserve proxies included years of education and engagement in leisure activity domains. Group differences and predictors of responder status were examined using regression models controlling for stroke severity (NIHSS).

Results: 

Cognitive leisure activities emerged as the strongest predictor of responder status (OR = 4.84), whereas education and other leisure domains were not retained. Exploratory factor analysis revealed two baseline cognitive dimensions (Memory, Executive-Spatial), but responders did not show significantly higher baseline cognitive scores. Network analyses demonstrated a more integrated cognitive-motor architecture in responders, characterized by higher density and lower sparsity. Dexterity and delayed verbal recall showed the highest centrality in the responder network, alongside processing speed as a consistently contributing node across centrality indices.

Conclusion: 

Post-stroke cognitive reserve may be less dependent on a high cognitive performance or demographic proxies but may be due to a more integrative organization of cognitive-motor functioning. Our findings support a network-based conceptualization of cognitive reserve with direct implications for integrative rehabilitation strategies.


More at link.

Tuesday, June 16, 2026

RNA gene expression and cognitive reserve as determinants of post-ischaemic stroke cognitive recovery

 

Biomarkers do nothing for recovery unless you are mapping EXACT RECOVERY PROTOCOLS to them! You're all fired for useless shit!

RNA gene expression and cognitive reserve as determinants of post-ischaemic stroke cognitive recovery

Abstract

Cognitive impairment is a common yet under-recognised complication of ischaemic stroke (IS), with long-term effects on patient quality of life and rehabilitation outcomes. Identifying early biomarkers and protective factors such as cognitive reserve (CR) is essential for improving prognosis and guiding targeted interventions. This study aimed to determine the following: (i) RNA gene expression profiling during acute stroke and (ii) the associations between target genes as well as clinical factors and cognitive impairment during an acute event and at the 3-month follow-up. A three-month prospective cohort study involving 24 adults with mild to moderate IS and 24 age- and sex-matched controls admitted to Hospital Canselor Tuanku Muhriz, Malaysia, was conducted. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) within 48 h of stroke and at 3 months. Peripheral blood samples were collected for RNA extraction, and gene expression was analysed using RT² Profiler PCR arrays. Cognitive reserve was measured using the Cognitive Reserve Index Questionnaire (CRI-q). Statistical analyses included chi-square and independent t tests. At baseline, 83.3% of IS patients exhibited cognitive impairment (mean age 64.6 ± 10.5 years). Increased age (p = 0.006), low education level (p = 0.010), diabetes mellitus (p = 0.010), CRI-Education (p = 0.010) and CRI-Working Activity (p = 0.009) were significantly associated with baseline cognitive impairment. These clinical and CR factors survived False Discovery Rate (FDR) correction at the baseline stage (p < 0.05). However, at the 3-month follow-up, no clinical or CR factors remained statistically significant after FDR correction. Regarding gene expression, while MAPK1 (p = 0.029) and CAPZB (p = 0.042) were nominally upregulated in patients, and RCOR1 (p = 0.043) showed a nominal association with baseline impairment, no genetic markers survived FDR correction at either time point. Age, diabetes, and cognitive reserve are robust determinants of cognitive status during the acute phase of ischaemic stroke. The loss of significance at 3 months suggests these factors are primary drivers of initial functional buffering rather than long-term recovery trajectories in this cohort. CR should be utilised as a prognostic stratification tool during admission to identify high-risk patients rather than as a direct target for acute intervention. Future large-scale studies are required to validate whether the observed nominal gene expression trends can serve as reliable biomarkers for long-term recovery.

Thursday, June 4, 2026

Does Brain Reserve Attenuate the Effects of Alzheimer Disease Pathology?

 

Have your competent? doctor give you EXACT PROTOCOLS TO BUILD BRAIN RESERVE and thus prevent dementia post stroke! Oh, can't or won't do that? INCOMPETENCE PERSONIFIED! Fire them! 

(My cognitive reserve was obviously high enough to withstand the stroke quite well. But NO one can tell me how or if I can build it up again to prevent dementia.)

Does Brain Reserve Attenuate the Effects of Alzheimer Disease Pathology?

Greater brain reserve and higher socioeconomic status were associated with reduced cognitive vulnerability to Alzheimer disease pathology among cognitively unimpaired older adults.

Greater cognitive and brain reserve may buffer the cognitive consequences of Alzheimer disease (AD) pathology, according to a study published in Neurology.


Researchers from AdventHealth Research Institute in the United States evaluated whether measures of cognitive and brain reserve modified the relationship between AD pathology and cognitive performance using baseline data from the Investigating Gains in Neurocognition in an Intervention Trial of Exercise (IGNITE) study (ClinicalTrials.gov Identifier: NCT02875301). 

Adults (N=621) aged 65 to 80 years who were cognitively unimpaired and physically inactive between 2017 and 2020 underwent cognitive assessment, magnetic resonance imaging (MRI), and plasma sampling for phosphorylated tau (p-tau) 217. A subset of participants (n=355) also underwent positron emission tomography (PET). The primary outcome was the effect of brain-predicted age difference (brain-PAD) and volumetric AD phenotype on cognitive performance. Objective socioeconomic status (SES) was calculated as a composite of annual family income, total savings, debt-adjusted savings, and duration of standard of living maintenance if current income was lost.

 

[W]e found some evidence that higher SES weakens the relationship between AD pathology and cognitive function, highlighting the need for further research in this area and to address socioeconomic inequalities…

The study population was 71% women and 75% White, with a mean (SD) age of 69.9 (3.8) years. The participants had completed a mean (SD) of 16.3 (2.2) years of education, and mean (SD) objective SES was 0.0 (0.91). In addition, 27% were apolipoprotein E (APOE) ε4 carriers, mean (SD) Montreal Cognitive Assessment (MoCA) score was 25.8 (2.6), and mean (SD) p-tau217 level was 0.43 (0.28) pg/mL.

The cohort had a mean (SD) brain-PAD of -4.05 (6.7) years and a mean (SD) AD signature of 64,958.6 (5387.4) mm3.

The AD signature was negatively correlated with brain-PAD (r, -0.204; P ≤.001) and positively correlated with executive function/attentional control (r, 0.217; P ≤.001), working memory (r, 0.214; P ≤.001), processing speed (r, 0.197; P ≤.001), visuospatial function (r, 0.193; P ≤.001), and episodic memory (r, 0.132; P ≤.001).

Years of education (β range, 0.18-0.30; all P <.001) and objective SES (β range, 0.11-0.21; all P <.004) were significantly associated with cognitive performance across domains. However, years of education did not moderate the relationship between p-tau217 and cognitive outcomes.

Significant brain-PAD-by-p-tau217 interactions were observed for working memory (β, -0.10; P <.01), episodic memory (β, -0.09; P <.05), processing speed (β, -0.08; P <.05), and executive function/attentional control (β, -0.08; P <.05). When AD signature was included in the brain-PAD moderation analysis, brain-PAD continued to interact with p-tau217 levels for working memory (β, -0.10; P =.008), episodic memory (β, -0.08; P =.025), and executive function/attentional control (β, -0.07; P =.044).

Volumetric AD signature did not moderate the relationship between p-tau17 or PET centiloids and cognitive outcomes.

Study limitations include the cross-sectional design, lack of PET data from the full cohort, and limited generalizability because the population was relatively well educated and predominantly non-Hispanic White.

The study authors concluded, “These results suggest that greater brain reserve may help buffer the cognitive consequences of AD pathology.” They continued, “In addition, we found some evidence that higher SES weakens the relationship between AD pathology and cognitive function, highlighting the need for further research in this area and to address socioeconomic inequalities as contributors to improving brain health.”

Disclosures: One study author declared affiliations with biotech, pharmaceutical, and/or device companies. Please see the original reference for a full list of authors’ disclosures. 

Friday, May 22, 2026

A 'Youthful' Brain May Boost Alzheimer's Resilience

 Ask your competent? doctor EXACTLY how to have a youthful brain! No knowledge, fire them and have them fired for incompetence! Dead wood needs to be removed unceremoniously! They do know exactly why Bernadette the nun was able to function quite well even with Alzheimers? NO? They incompetently know nothing about Bernadette? That's a game changer showing complete incompetence!

A 'Youthful' Brain May Boost Alzheimer's Resilience

Key Takeaways

  • Preserved global brain structure appeared to buffer cognitive decline in people with Alzheimer's pathology.
  • Younger-appearing brains had weaker links between pathology and poorer outcomes in multiple cognitive domains.
  • Other measures of brain reserve or cognitive reserve showed no clear protective cognitive effect.

Greater structural brain integrity appeared to buffer the cognitive consequences of Alzheimer's disease pathology, cross-sectional data suggested.

The study evaluated two markers of brain reserve -- brain-predicted age difference (brain-PAD) and a volumetric Alzheimer's disease signature -- in cognitively unimpaired older adults. Brain-PAD, a marker of overall structural brain health, uses MRI data to determine how much older or younger a brain appears relative to chronological age.

Two markers of cognitive reserve, socioeconomic status and years of education, also were assessed.

Brain-PAD moderated the association between Alzheimer's pathology and multiple cognitive domains, including episodic memory (β = -0.09), processing speed (β = -0.08), working memory (β = -0.10), and executive function/attentional control (β = -0.08), reported Kelsey Sewell, PhD, of Murdoch University School of Allied Health in Perth, Australia, and co-authors."Specifically, the negative association of greater Alzheimer's disease pathology with poorer cognition was weakest in individuals with younger-appearing brains," the researchers wrote in Neurology.

A latent socioeconomic status score also appeared to influence the relationship between Alzheimer's pathology and episodic memory (β = 0.08), but the association did not remain significant after correction for multiple comparisons, Sewell and colleagues noted. Neither years of education nor the volumetric Alzheimer's signature moderated pathology-cognition associations, they added.

"Our main finding was that maintaining good overall brain health may help reduce the impact of Alzheimer's‑related changes on cognitive function," Sewell said in a statement. "Things like exercise, maintaining a healthy diet, sleeping well, and finding new cognitive challenges can help to maintain a healthy brain."

About 20% to 30% of adults ages 65 to 75 show evidence of Alzheimer's pathology despite having no measurable cognitive impairment, Sewell and co-authors said. "This phenomenon is often attributed to resilience, a general term describing multiple reserve-related processes that enable the brain to maintain higher levels of cognitive performance and function with aging or disease," they wrote."Within this framework, two key concepts are 'cognitive reserve' defined as a property of the brain that allows for cognitive performance better than expected given the degree of brain changes and pathology, and 'brain reserve' defined as the neurobiological capacity of the brain at a given point in time," they stated.

The findings of this study support "the idea that preserved global brain structure reduces vulnerability to cognitive decline in the face of emerging pathology," noted Maria Carrigan, MSc, and Colin Groot, MSc, both of Amsterdam University Medical Center in the Netherlands, in an accompanying editorial.

"For clinicians, the key message is that preserved global brain health seems to matter even before symptoms emerge," Carrigan and Groot wrote.

"The study also raises important questions for future research," the editorialists added. "What biological processes underlie a younger-appearing brain? To what extent is brain-PAD modifiable through interventions targeting physical activity, vascular risk factors, or other lifestyle exposures? In addition, how does brain-PAD interact longitudinally with amyloid and tau accumulation to influence cognitive trajectories?"

Sewell and colleagues examined whether cognitive and brain reserve modified the relationship between Alzheimer's pathology and cognition in 621 cognitively unimpaired, physically inactive participants in the IGNITE exercise trial in the U.S.

Mean age was 70 years and 71% were women. The mean brain-PAD of the cohort was -4.05, indicating that participants' brains appeared younger than their chronological age, on average.

Alzheimer's pathology was assessed using plasma phosphorylated tau (p-tau)-217. A subgroup of 355 participants also underwent tau PET imaging. Brain age was estimated from T1-weighted images.

The researchers noted several limitations. The study was cross-sectional and could not determine causality: while accelerated brain aging might worsen the cognitive effects of Alzheimer's pathology, it's also possible that people with more advanced brain ages are more vulnerable to accumulating pathology.

Emerging evidence suggests that p-tau217 may not be entirely specific to Alzheimer's pathology, they acknowledged. Findings from participants who had tau PET imaging supported the associations seen in the study.

Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Connect:
Disclosures

Sewell had no disclosures. One co-author disclosed being an inventor on a University of Pittsburgh patent regarding the IPMS assay for Aβ peptides and serving as a consultant for Quanterix.

Carrigan and Groot had no relevant disclosures.

Friday, May 8, 2026

The 80-Year-Olds With 50-Year-Old Memory: What They’re Doing Differently by mindbodygreen

 Have your competent? doctor DETAIL EXACTLY IN A PROTOCOL how to benefit from this!

I've got massive social connections and I've always considered myself an introvert and quite shy. Not anymore. 

The 80-Year-Olds With 50-Year-Old Memory: What They’re Doing Differently

 In the past decade, our understanding of cognitive decline has profoundly shifted. We once thought that brain aging was inevitable—we all marched towards our fate, predetermined by genetics, with decline seen as a natural and unavoidable endpoint. But, of course, individuals have always defied these expectations. They remained remarkably sharp late into life, often performing on memory tests at the level of people 30 years younger. They’ve long fascinated researchers. For the past 25 years, researchers at Northwestern University have been studying a group of these remarkable individuals, known as SuperAgers, to understand what sets their brains apart. Now, a landmark study from the program reveals two distinct pathways to exceptional cognitive aging—and one lifestyle factor that nearly all SuperAgers share.

The 25-year-long research that has made this all possible

 The term "SuperAger" was coined by Northwestern's Mesulam Center for Cognitive Neurology and Alzheimer's Disease in 2008 to describe adults 80 and older who maintain memory performance on par with people in their 50s and 60s. Since 2000, the SuperAging Research Program has followed 290 participants, tracking their cognitive function over time. To qualify as a SuperAger, participants must score at least 9 out of 15 on a delayed word recall test—a threshold typically seen in people decades younger. What makes this research so significant is the brain donation component. Of the 290 participants, 77 have donated their brains for postmortem analysis, giving researchers an unprecedented window into the biological mechanisms behind exceptional aging. This kind of long-term, brain-based research is incredibly rare—and essential. It allows scientists to connect real-life cognitive performance with what’s physically happening in the brain, offering one of the clearest pictures yet of how memory can be preserved over decades. 

What this study found

 We know from previous research that some brains collect and accumulate damaging proteins, resulting in impaired cognitive function and sometimes later leading to Alzheimer's or Dementia. However, we also know (quite surprisingly) accumulation of these proteins don’t always lead to a diseased brain. The SuperAging Research Program has been studying this exact distinction, trying to understand why some brains decline while others don’t. The study, recently published in Alzheimer's & Dementia: The Journal of the Alzheimer’s Association, outlined the two distinct pathways to maintaining sharp memory. The first is resistance—these SuperAgers naturally avoided the buildup of amyloid plaques and tau tangles, the proteins associated with Alzheimer's disease. Their brains showed minimal accumulation of these harmful deposits, making them naturally less susceptible to cognitive decline. But the second pathway is resilience. Some SuperAgers had significant plaque and tangle buildup—levels that would typically cause cognitive decline—yet their memory remained intact. Their brains somehow tolerated the damage without losing function. Researchers also identified unique structural features in SuperAger brains: a thicker anterior cingulate cortex1(a region tied to attention and decision-making), morevon Economo neurons (specialized cells linked to social cognition), andlarger neurons in the entorhinal cortex (a memory hub that's often the first area affected by Alzheimer's). 

Why resilience may matter more than resistance

 This finding reframes how we think about brain aging. You don't need a "perfect" brain to maintain exceptional memory—some SuperAgers had Alzheimer's-level pathology but showed no symptoms. The resilience pathway suggests that the brain's ability to compensate for damage may be just as important as preventing it in the first place.In the past decade, our understanding of cognitive decline has profoundly shifted. We once thought that brain aging was inevitable—we all marched towards our fate, predetermined by genetics, with decline seen as a natural and unavoidable endpoint. But, of course, individuals have always defied these expectations. They remained remarkably sharp late into life, often performing on memory tests at the level of people 30 years younger. They’ve long fascinated researchers. For the past 25 years, researchers at Northwestern University have been studying a group of these remarkable individuals, known as SuperAgers, to understand what sets their brains apart. Now, a landmark study from the program reveals two distinct pathways to exceptional cognitive aging—and one lifestyle factor that nearly all SuperAgers share. 

The 25-year-long research that has made this all possible

 The term "SuperAger" was coined by Northwestern's Mesulam Center for Cognitive Neurology and Alzheimer's Disease in 2008 to describe adults 80 and older who maintain memory performance on par with people in their 50s and 60s. Since 2000, the SuperAging Research Program has followed 290 participants, tracking their cognitive function over time. To qualify as a SuperAger, participants must score at least 9 out of 15 on a delayed word recall test—a threshold typically seen in people decades younger. What makes this research so significant is the brain donation component. Of the 290 participants, 77 have donated their brains for postmortem analysis, giving researchers an unprecedented window into the biological mechanisms behind exceptional aging. This kind of long-term, brain-based research is incredibly rare—and essential. It allows scientists to connect real-life cognitive performance with what’s physically happening in the brain, offering one of the clearest pictures yet of how memory can be preserved over decades. 

What this study found

 We know from previous research that some brains collect and accumulate damaging proteins, resulting in impaired cognitive function and sometimes later leading to Alzheimer's or Dementia. However, we also know (quite surprisingly) accumulation of these proteins don’t always lead to a diseased brain. The SuperAging Research Program has been studying this exact distinction, trying to understand why some brains decline while others don’t. The study, recently published in Alzheimer's & Dementia: The Journal of the Alzheimer’s Association, outlined the two distinct pathways to maintaining sharp memory. The first is resistance—these SuperAgers naturally avoided the buildup of amyloid plaques and tau tangles, the proteins associated with Alzheimer's disease. Their brains showed minimal accumulation of these harmful deposits, making them naturally less susceptible to cognitive decline. But the second pathway is resilience. Some SuperAgers had significant plaque and tangle buildup—levels that would typically cause cognitive decline—yet their memory remained intact. Their brains somehow tolerated the damage without losing function. Researchers also identified unique structural features in SuperAger brains: a thicker anterior cingulate cortex1  (a region tied to attention and decision-making), more von Economo neurons(specialized cells linked to social cognition), and larger neurons in the entorhinal cortex (a memory hub that's often the first area affected by Alzheimer's). 

Why resilience may matter more than resistance

 This finding reframes how we think about brain aging. You don't need a "perfect" brain to maintain exceptional memory—some SuperAgers had Alzheimer's-level pathology but showed no symptoms. The resilience pathway suggests that the brain's ability to compensate for damage may be just as important as preventing it in the first place.For researchers, this opens new avenues for intervention. Rather than focusing solely on preventing plaque buildup, future therapies might also target the brain's capacity to function despite it—zeroing in on some of the structural elements mentioned above.  

The lifestyle factor that linked nearly all SuperAgers

 When researchers looked at what SuperAgers had in common, one factor stood out: social connection. While their exercise habits, diets, and other lifestyle choices varied widely, most SuperAgers were highly social and maintained close, meaningful relationships throughout their lives.>This aligns with a growing body of research linking social engagement to cognitive health. Strong relationships may protect the brain by reducing chronic stress, promoting mental stimulation, and supporting emotional well-being. A few ways to prioritize connection for brain health:Nurture existing relationships:Regular check-ins with close friends or family (even brief phone calls!) strengthen bonds over time. Studies regularly show that experiencing love—like you have for partners, family and friends—improves brain function. Join a class, club, or volunteer group that aligns with your interests to expand your circle. Research has found that social activities like this not only improve long-term cognitive function, but boost mental health and physical activity. Engage in small talk with those in your direct community:We may think only deep, long-lasting relationships matter (and they do!) research also indicates that the brief interactions we have with folks day-to-day also plays a role. Think: the morning chatter you share with the barista on your coffee run, talking about weekend plans during checkout at the grocery store, or watercooler talk at work. 

The takeaway

This 25-year study reveals that exceptional memory in your 80s can happen through two pathways: resisting brain changes or being resilient to them. The common thread among SuperAgers isn't a perfect diet or exercise routine, but maintaining close social connections. In other words, brain longevity may be less about doing everything “right” and more about consistently investing in the relationships that keep you mentally and emotionally engaged. And how lovely is that?

So if you do one thing today after reading this article, I sincerely hope it's this: Make the phone call, schedule the coffee date, plan the girls trip: Prioritizing meaningful relationships may be one of the most powerful things you can do for long-term brain health. 

Monday, May 4, 2026

“Yes, And…” Might Be the Smartest Thing You Say All Week by Super Age

 I normally say yes to most suggested activities. As a friend once commented when he asked me if I wanted to join a trip to Madagascar; 'Dean waited a half second before saying yes'. I'm always up for new experiences. I need as much cognitive reserve as possible since I think I used most of mine up just surviving the stroke. Not quite the improvisation this article recommends but I think similar enough.

“Yes, And…” Might Be the Smartest Thing You Say All Week

Monday, April 20, 2026

RNA gene expression and cognitive reserve as determinants of post-ischaemic stroke cognitive recovery

 How is your competent? doctor rebuilding your cognitive reserve enough to prevent dementia? This told me nothing.

Do you prefer your doctor, hospital and board of director's incompetence NOT KNOWING? OR NOT DOING? Your choice; let them be incompetent or demand action!

OH NO! your doctor KNOWS NOTHING AND DOES NOTHING! 

RNA gene expression and cognitive reserve as determinants of post-ischaemic stroke cognitive recovery


We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Abstract

Cognitive impairment is a common yet under-recognised complication of ischaemic stroke (IS), with long-term effects on patient quality of life and rehabilitation outcomes. Identifying early biomarkers and protective factors such as cognitive reserve (CR) is essential for improving prognosis and guiding targeted interventions. This study aimed to determine the following: (i) RNA gene expression profiling during acute stroke and (ii) the associations between target genes as well as clinical factors and cognitive impairment during an acute event and at the 3-month follow-up. A three-month prospective cohort study involving 24 adults with mild to moderate IS and 24 age- and sex-matched controls admitted to Hospital Canselor Tuanku Muhriz, Malaysia, was conducted. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) within 48 h of stroke and at 3 months. Peripheral blood samples were collected for RNA extraction, and gene expression was analysed using RT² Profiler PCR arrays. Cognitive reserve was measured using the Cognitive Reserve Index Questionnaire (CRI-q). Statistical analyses included chi-square and independent t tests. At baseline, 83.3% of IS patients exhibited cognitive impairment (mean age 64.6 ± 10.5 years). Increased age (p = 0.006), low education level (p = 0.010), diabetes mellitus (p = 0.010), CRI-Education (p = 0.010) and CRI-Working Activity (p = 0.009) were significantly associated with baseline cognitive impairment. These clinical and CR factors survived False Discovery Rate (FDR) correction at the baseline stage (p < 0.05). However, at the 3-month follow-up, no clinical or CR factors remained statistically significant after FDR correction. Regarding gene expression, while MAPK1 (p = 0.029) and CAPZB (p = 0.042) were nominally upregulated in patients, and RCOR1 (p = 0.043) showed a nominal association with baseline impairment, no genetic markers survived FDR correction at either time point. Age, diabetes, and cognitive reserve are robust determinants of cognitive status during the acute phase of ischaemic stroke. The loss of significance at 3 months suggests these factors are primary drivers of initial functional buffering rather than long-term recovery trajectories in this cohort. CR should be utilised as a prognostic stratification tool during admission to identify high-risk patients rather than as a direct target for acute intervention. Future large-scale studies are required to validate whether the observed nominal gene expression trends can serve as reliable biomarkers for long-term recovery.

Data availability

The datasets presented in this article are not readily available because the data are part of an ongoing study. Requests to access the datasets should be directed to Dr. Nurul Nadiah, email: [p109270@siswa.ukm.edu.my] (mailto: p109270@siswa.ukm.edu.my) .